Atlas Trials

Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer

Clinical trial NCT06478225 · RECRUITING

Trial details

NCT number
NCT06478225
Sponsor
RenJi Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Tumor Pancreas
Start date
2024-05-07
Primary completion
2027-03-31
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.